Paid Clinical Trials in Reno, NV
As of September 2026, 166 paid clinical trials are recruiting in Reno, Nevada. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Reno offers studies at sites including Renown Regional Medical Center for conditions such as Geographic Atrophy, Malignant Solid Neoplasm, Metastatic Breast Cancer, Non-small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Reno
Trials by drug in Reno
Filter results
Newly added in Reno
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
157 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Study of DONQ52 in Active Celiac Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Top Research Study Locations in Reno
Researchers run research studies in Reno, NV at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Renown Regional Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 74 |
| Sierra Eye Associates | Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Age - Related Macular Degeneration (AMD) | 19 |
| Saint Mary's Regional Medical Center | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Acute Lymphoblastic Leukemia | 17 |
| Radiation Oncology Associates | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 7 |
| Cancer Care Specialists | Metastatic Breast Cancer, Non-small Cell Lung Cancer, Early Breast Cancer | 7 |
| Renown Health Medical Oncology | Advanced Breast Cancer, Advanced Hepatocellular Carcinoma, Breast Cancer | 6 |
| Renown Office of Clinical Research | Advanced Hepatocellular Carcinoma, Cachexia, Carcinoma, Hepatocellular | 4 |
| Renown Regional Medical Center-Renown Health Medical Oncology | Non Small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer | 4 |
| Center of Hope | Cervical Cancer, Endometrioid Ovarian Cancer, Fallopian Tube Cancer | 3 |
| Advanced Research Institute - Reno | Chronic Idiopathic Constipation (CIC), Migraine | 2 |
| Nevada Advanced Pain Specialists | Degenerative Disc Disease, Disc Degeneration, Lumbar Discogenic Pain | 2 |
| Renascor Clinical Research | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Obesity, Abdominal | 2 |
| Renown Health | Cancer, Parkinson's Disease | 2 |
| Skin Cancer and Dermatology Institute | Atopic, Atopic Dermatitis, Dermatitis | 2 |
| Urology Nevada | Kidney Calculi; Ureteral Calculi, Overactive Bladder (OAB) | 2 |
| Northern Nevada Endocrinology | Adult Growth Hormone Deficiency, Hypothyroidism | 2 |
| Skin Cancer and Dermatology Institute - Reno | Overweight or Obesity, Psoriasis, Alopecia Areata | 2 |
| The Center Of Hope | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Advanced Research Institute | Celiac Disease | 1 |
| Advanced Research Institute Reno | Migraine | 1 |
| Advanced Research Institute-Reno | Acute Migraine | 1 |
| Akero Clinical Study Site | MASH With Fibrosis, NASH With Fibrosis | 1 |
| Ambros Clinical Trial Site | Complex Regional Pain Syndrome Type I | 1 |
| Ascendis Pharma Investigational Site | Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases | 1 |
Active & Upcoming Studies in Reno (2026)
Recruiting trials in Reno grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (80 active studies)
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · Hoffmann-La Roche
- A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer · Phase 3 · AstraZeneca
Eye & vision (15 active studies)
- An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) · Phase 1, Phase 2 · Complement Therapeutics
- Phase 2 Study of ADX-038 in Participants With Geographic Atrophy · Phase 2 · ADARx Pharmaceuticals, Inc.
Neurology & pain (6 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (6 active studies)
- Gathering Evidence on Best Practices for Lay Rescuer CPR Training · University of Nevada, Reno
- LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 · Phase 3 · Tenax Therapeutics, Inc.
Diabetes & metabolic (4 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- SPYRAL GEMINI Pilot Study · Medtronic Vascular
Mental health & behavior (3 active studies)
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
- The Social Regulation of Threat-related Vigilance and Arousal · University of Nevada, Reno
Common conditions studied in Reno
- Geographic Atrophy (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Metastatic Breast Cancer (5 active studies)
- Non-small Cell Lung Cancer (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Breast Cancer (4 active studies)
Leading research sponsors in Reno
- AbbVie
- Children's Oncology Group
- Alliance for Clinical Trials in Oncology
- Merck Sharp & Dohme LLC
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Reno?
There are approximately 166 recruiting clinical trials in Reno, Nevada listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Reno pay participants?
Most recruiting trials in Reno compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Reno?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Reno?
The most common conditions under active study in Reno include Geographic Atrophy (5), Malignant Solid Neoplasm (5), Metastatic Breast Cancer (5), Non-small Cell Lung Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Reno?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Reno on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Reno?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Reno?
Recruiting research sites in Reno include Renown Regional Medical Center, Sierra Eye Associates, Saint Mary's Regional Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Reno right now?
The largest active categories in Reno are Cancer & tumors (80), Eye & vision (15), Neurology & pain (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.